犬尿氨酸上调巨噬细胞MS4A4A促进结直肠癌免疫逃逸的分子机制
批准号:
82073063
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
沈智勇
依托单位:
学科分类:
肿瘤代谢
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
沈智勇
中文摘要
肿瘤的发生、发展是与免疫微环境相互博弈的结果。肿瘤细胞与免疫细胞间的代谢竞争及代谢产物相互作用是促使肿瘤免疫逃逸的重要因素,但结直肠癌细胞通过代谢产物调控肿瘤相关巨噬细胞(TAM)的机制尚未阐明。我们预实验结果发现,结直肠癌细胞分泌的犬尿氨酸,可能通过激活TAM中AHR-KLF4通路,上调MS4A4A的表达,继而促使TAM向M2型极化,并导致T细胞耗竭。因此我们提出肿瘤细胞代谢产物犬尿氨酸上调TAM中MS4A4A促结直肠癌免疫逃逸的科学假说。本项目拟:1.阐明MS4A4A调控TAM极化及免疫微环境促结直肠癌免疫逃逸的作用及机制;2.揭示犬尿氨酸激活TAM中AHR-KLF4通路调控MS4A4A表达的分子机制;3.探讨阻断MS4A4A在结直肠癌免疫治疗的作用。本研究着眼于探寻TAM极化的关键环节,旨在揭示肿瘤代谢重塑免疫微环境的新机制,为结直肠癌预后判断及免疫治疗提供新的靶点和策略。
英文摘要
The occurrence and development of tumors are the result of competition with the immune microenvironment. Metabolic competition and metabolite interactions between tumor cells and immune cells are important factors that promote tumor immune escape, but the mechanism by which colorectal cancer (CRC) cells regulate tumor-associated macrophages (TAM) through metabolites has not been elucidated. Our previous work found that kynurenine secreted by CRC cells could regulate the expression of Membrane Spanning 4-Domains A4A (MS4A4A) in TAM through AHR-KLF4 pathway, which led to macrophages M2 polarization and caused T cell exhaustion. Based on our preliminary results, we hypothesize that kynurenine, as a metabolite of tumor cells, could promote immune escape of CRC via up-regulating MS4A4A expression in TAM. To verify this hypothesis, firstly, we will further clarify the function and mechanism of MS4A4A in regulating TAM polarization and immune microenvironment to promote immune escape of CRC. Secondly, we will elucidate the molecular mechanism by which kynurenine activates the AHR-KLF4 pathway in TAM to regulate the expression of MS4A4A. Finally, we will explore the effect of blocking MS4A4A in immunotherapy of CRC. This study focuses on exploring the key aspects of TAM polarization, and aims to reveal new mechanisms of tumor metabolism remodeling the immune microenvironment, and provides new targets and strategies for prognosis and immunotherapy of CRC.
免疫检查点阻断疗法虽然释放了T细胞对肿瘤细胞的杀伤效应,但却受到免疫抑制性的髓系细胞的抑制。跨膜蛋白MS4A4A选择性地由巨噬细胞系细胞表达,特异性地在肿瘤相关巨噬细胞(TAMs)中高度表达,但其功能尚不明确。在本研究中,我们发现MS4A4A的体内抑制和抗MS4A4A单抗治疗均能明显抑制结直肠癌的生长并改善免疫检查点抑制剂的疗效。流式细胞术和CyTOF分析显示,MS4A4A阻断治疗重塑了肿瘤免疫微环境,导致M2型TAMs和耗竭型T细胞浸润减少,CD8+T细胞浸润增加。更重要的是,这种联合疗法对于大体积、治疗耐药的结直肠癌仍然有效,在进一步与放疗联合时可引起肿瘤完全消退。本研究首次揭示了MS4A4A+ TAMs在调控肿瘤免疫逃逸中所发挥的关键作用,并探讨了MS4A4A阻断治疗对免疫检查点抑制剂的增敏作用,为开发结直肠癌免疫治疗联合策略提供了新的方向。
跨膜蛋白MS4A4A调控巨噬细胞M2极化介导结直肠癌免疫逃逸的分子机制
-
批准号:--
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:沈智勇
-
依托单位:
结肠癌细胞核内S100P转录调控POTEE表达对促进肿瘤增殖的作用机制
-
批准号:31601023
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2016
-
负责人:沈智勇
-
依托单位:
国内基金
海外基金